Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.68
-0.04 (-0.67%)
Dec 31, 2025, 10:48 AM EST - Market open
Novavax Stock Forecast
Stock Price Forecast
The 8 analysts that cover Novavax stock have a consensus rating of "Hold" and an average price target of $9.75, which forecasts a 46.07% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $18.
Price Target: $9.75 (+46.07%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 18, 2025.
Analyst Ratings
The average analyst rating for Novavax stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 2 | 3 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 1 | 1 |
| Sell | 1 | 2 | 2 | 2 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 7 | 7 | 6 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $7 → $6 | Sell | Maintains | $7 → $6 | -10.11% | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $18 → $16 | Strong Buy | Reiterates | $18 → $16 | +139.70% | Nov 10, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +4.87% | Nov 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +169.66% | Oct 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +64.79% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
1.08B
from 682.16M
Increased by 58.91%
Revenue Next Year
383.44M
from 1.08B
Decreased by -64.63%
EPS This Year
2.30
from -1.23
EPS Next Year
-0.47
from 2.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.2B | 592.5M | ||||
| Avg | 1.1B | 383.4M | ||||
| Low | 1.0B | 244.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.1% | -45.3% | ||||
| Avg | 58.9% | -64.6% | ||||
| Low | 50.4% | -77.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.20 | 0.41 | ||||
| Avg | 2.30 | -0.47 | ||||
| Low | 1.80 | -0.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | -82.2% | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.